Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
These symptoms usually subside within a few days
Glucagon-Like Peptide-1 Receptor Agonists Are Promising for the Treatment of Brain Diseases: an Outlook from the Perspective of Integrative Physiology
But the human data gap is real
It was investigated as a candidate obesity therapeutic but did not meet its primary endpoints in clinical trials, and no marketing approval followed
TGF-/Smad pathway, that may in part mediate the antiproliferative effects of DA, was found down-regulated in DA-resistant prolactinomas compared to normal human anterior pituitaries ( Novel Mechanism in Drug Resistance of Pituitary Tumors: A Role for Cytoskeleton Recently, cytoskeleton has emerged as novel player implicated in the complex mechanisms of pharmacological resistance of pituitary tumors to DA and SS
US$ 21.13
US$ 20.63
US$ 29.30
